-

Innovaderm, Recognized by Clinical Leaders CRO Leadership Awards for the 4th Consecutive Year

MONTREAL--(BUSINESS WIRE)--Innovaderm, the leading medical dermatology and aesthetics Contract Research Organization (CRO), today announced that it has been selected by Clinical Leaders CRO Leadership Awards for the fourth consecutive year, excelling across core categories of Expertise, Capabilities, Quality, and Reliability.

Clinical Leaders CRO Leadership Awards, which include a collaboration with ISR Reports, provide readers with accurate and reliable customer feedback to assist them in choosing a reputable CRO partner. This year, more than 40 CROs were assessed on approximately 20 performance metrics on work completed in the past 18 months.

Innovaderm won top performer for “small pharma” in the Capabilities, Quality, and Reliability categories, and named champion in the Expertise (Overall, Small Pharma) category.

“We are proud to be recognized by the CRO Leadership Awards for the 4th year running,” said Cedric Burg, COO at Innovaderm. “This honor is a testament to our unwavering commitment to excellence in dermatology and aesthetics clinical research. Our team’s dedication to providing top-tier service and delivering quality results has been instrumental in achieving this recognition. We remain committed to our mission of improving patients’ lives and will continue to strive for excellence in all that we do.”

With nearly 25 years of success and deep expertise in medical dermatology and aesthetics, Innovaderm stands as a leader in dermatology clinical research. The CRO’s comprehensive approach includes full-service capabilities and stand-alone biometrics and clinical regulatory services across all phases of clinical trials. Innovaderm excels in managing both late phase and early phase & translational studies. The operational teams, established in Europe and North America, are dedicated to improving patient lives. This commitment to excellence underscores every aspect of Innovaderm’s mission.

Innovaderm Research Inc.

Innovaderm Research Inc. is the leading full-service dermatology CRO. Founded in 2000, Innovaderm’s deep expertise and experience enable the ability to operationalize all aspects of clinical research, and deliver excellence across early to late phase studies. Innovaderm’s mission is to drive innovative research initiatives towards the goal of improving patients’ lives. To learn about Innovaderm’s services, visit our website.

Innovaderm Research Inc.

Contacts

Media:
Lisa Barbadora
Barbadora Ink for Innovaderm Research
barbadora@barbadoraink.com

Marla Kertzman
Barbadora Ink for Innovaderm Research
marla@thoroughbred-communications.com

Innovaderm Research Inc.


Release Summary
CRO Leadership Awards 2024

Contacts

Media:
Lisa Barbadora
Barbadora Ink for Innovaderm Research
barbadora@barbadoraink.com

Marla Kertzman
Barbadora Ink for Innovaderm Research
marla@thoroughbred-communications.com

Social Media Profiles
More News From Innovaderm Research Inc.

Indero Announces Breakthrough Method for Early-Phase Evaluation of Topical Drugs Using Quantitative Gene Expression

MONTREAL--(BUSINESS WIRE)--Indero is proud to announce the successful completion of an internally funded study that introduces a novel approach to evaluating topical new chemical entities (NCE) in early-phase clinical research. This innovative method leverages quantitative gene expression analysis to assess drug efficacy rapidly and cost effectively. Dr. Robert Bissonnette, Executive Chairman and Founder of Indero, who initiated and led the study, shared his excitement about the results: “Our g...

Indero Celebrates 25 Years and Looks to the Future of Clinical Research

MONTREAL--(BUSINESS WIRE)--Indero, the niche CRO formerly known as Innovaderm, is celebrating 25 years of advancing clinical research. From its roots as a dermatology site in Montreal, Indero has grown into a global organization with capabilities in more than 30 countries across 4 continents and has earned a reputation for delivering expert, efficient trials in dermatology and, more recently, rheumatology. Indero was founded as Innovaderm in 2000, starting as a clinical site and now a global CR...

Innovaderm Research Rebrands as Indero, a Dual-Focus CRO

MONTREAL--(BUSINESS WIRE)--Innovaderm, a leading clinical research organization (CRO), is excited to reveal a major rebranding to Indero, with immediate effect. The new brand identity reinforces the company’s dual focus on rheumatology and dermatology and recognizes the close synergy between these fields. Innovaderm has over 25 years of clinical research experience within dermatology, and recognizes that many inflammatory and autoimmune conditions manifest across both the skin and the musculosk...
Back to Newsroom